A founder deletion in the <i>TRPM1</i> gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews.

A founder deletion in the TRPM1 gene associated with congenital stationary night blindness and myopia is highly prevalent in Ashkenazi Jews.

Hirsch, Yoel; Zeevi, David A; Lam, Byron L; Scher, Sholem Y; Bringer, Rachel; Cherki, Bitya; Cohen, Cadina C; Muallem, Hagit; Chiang, John Pei-Wen; Pantrangi, Madhulatha; Ekstein, Josef; Johansson, Martin M.

Afiliação

Hirsch Y; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Brooklyn, NY USA.
Zeevi DA; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Jerusalem, Israel.
Lam BL; 3Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL USA.
Scher SY; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Brooklyn, NY USA.
Bringer R; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Jerusalem, Israel.
Cherki B; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Jerusalem, Israel.
Cohen CC; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Jerusalem, Israel.
Muallem H; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Jerusalem, Israel.
Chiang JP; Molecular Vision Laboratory, Hillsboro, OR USA.
Pantrangi M; PreventionGenetics, Marshfield, WI 54449 USA.
Ekstein J; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Brooklyn, NY USA.
Johansson MM; Dor Yeshorim, The Committee for Prevention of Jewish Genetic Diseases, Brooklyn, NY USA.